![logo](/logos/000403.SZ.webp)
Pacific Shuanglin Bio-pharmacy Co., LTD
SZSE:000403.SZ
21.78 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,328.723 | 2,405.188 | 1,971.734 | 1,049.938 | 915.657 | 859.843 | 685.378 | 567.436 | 500.269 | 489.496 | 477.716 | 469.824 | 461.068 | 545.673 | 465.911 | 578.801 | 645.031 | 674.9 | 742.951 | 669.811 | 651.812 | 467.956 | 422.25 | 381.184 | 349.952 | 191.571 | 157.446 | 143.333 | 141.891 |
Cost of Revenue
| 1,129.878 | 1,151.443 | 1,063.309 | 537.358 | 436.412 | 401.328 | 294.841 | 249.566 | 235.434 | 210.045 | 190.68 | 178.753 | 152.062 | 242.247 | 248.672 | 416.16 | 481.672 | 558.549 | 605.234 | 535.22 | 501.311 | 326.372 | 256.877 | 211.35 | 211.792 | 125.757 | 111.776 | 105.124 | 105.923 |
Gross Profit
| 1,198.845 | 1,253.745 | 908.425 | 512.58 | 479.244 | 458.516 | 390.537 | 317.871 | 264.835 | 279.451 | 287.035 | 291.072 | 309.007 | 303.426 | 217.238 | 162.641 | 163.359 | 116.351 | 137.717 | 134.591 | 150.501 | 141.584 | 165.373 | 169.834 | 138.16 | 65.814 | 45.67 | 38.21 | 35.968 |
Gross Profit Ratio
| 0.515 | 0.521 | 0.461 | 0.488 | 0.523 | 0.533 | 0.57 | 0.56 | 0.529 | 0.571 | 0.601 | 0.62 | 0.67 | 0.556 | 0.466 | 0.281 | 0.253 | 0.172 | 0.185 | 0.201 | 0.231 | 0.303 | 0.392 | 0.446 | 0.395 | 0.344 | 0.29 | 0.267 | 0.253 |
Reseach & Development Expenses
| 79.685 | 75.365 | 35.63 | 10.996 | 14.732 | 28.588 | 29.39 | 26.769 | 24.128 | 19.085 | 26.881 | 16.314 | 28.459 | 28.379 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 50.81 | 39.165 | 43.898 | 27.227 | 22.553 | 51.007 | 74.287 | 52.842 | 42.169 | 26.808 | 35.663 | 35.504 | 26.277 | 52.066 | 121.237 | 82.469 | 74.63 | 75.892 | 530.753 | 275.019 | 61.345 | 55.156 | 50.077 | 30.862 | 37.447 | 14.358 | 12.901 | 12.594 | 12.777 |
Selling & Marketing Expenses
| 285.567 | 399.569 | 229.27 | 158.624 | 144.642 | 146.42 | 78.151 | 49.545 | 11.125 | 6.698 | 17.672 | 16.204 | 21.05 | 22.316 | 21.718 | 27.423 | 31.672 | 40.106 | 47.281 | 32.336 | 18.329 | 15.945 | 11.298 | 10.408 | 11.225 | 6.566 | 7.336 | 4.192 | 3.562 |
SG&A
| 336.377 | 438.733 | 273.168 | 185.851 | 167.195 | 197.427 | 152.438 | 102.387 | 53.293 | 33.506 | 53.335 | 51.708 | 47.327 | 74.382 | 142.956 | 109.893 | 106.302 | 115.998 | 578.034 | 307.355 | 79.674 | 71.1 | 61.375 | 41.271 | 48.672 | 20.924 | 20.237 | 16.786 | 16.338 |
Other Expenses
| -1,633.584 | 128.245 | 150.035 | 92.832 | 90.842 | 107.95 | 87.364 | 13.64 | 55.045 | 47.597 | 113.186 | -25.749 | -20.191 | 23.597 | -0.713 | 200.024 | 117.054 | 14.862 | -82.868 | 14.381 | 4.003 | 10.551 | 20.233 | 23.78 | 25.833 | 0.339 | 3.689 | 7.943 | -1.534 |
Operating Expenses
| 1,633.584 | 642.344 | 458.833 | 289.678 | 272.77 | 333.965 | 269.192 | 227.852 | 158.393 | 134.118 | 152.919 | 136.429 | 143.373 | 163.518 | 145.029 | 111.867 | 107.644 | 117.726 | 580.884 | 308.988 | 80.594 | 72.364 | 62.326 | 42.174 | 50.141 | 22.145 | 21.249 | 17.52 | 17.355 |
Operating Income
| 695.14 | 663.429 | 460.427 | 220.296 | 180.038 | 130.986 | 83.636 | 55.154 | 68.318 | 100.251 | 58.866 | 53.132 | 53.218 | -8.923 | -20.381 | -0.037 | -31.539 | -103.419 | -540 | -225.939 | 35.027 | 43.289 | 83.711 | 122.718 | 87.611 | 34.402 | 21.329 | 19.926 | 12.838 |
Operating Income Ratio
| 0.299 | 0.276 | 0.234 | 0.21 | 0.197 | 0.152 | 0.122 | 0.097 | 0.137 | 0.205 | 0.123 | 0.113 | 0.115 | -0.016 | -0.044 | -0 | -0.049 | -0.153 | -0.727 | -0.337 | 0.054 | 0.093 | 0.198 | 0.322 | 0.25 | 0.18 | 0.135 | 0.139 | 0.09 |
Total Other Income Expenses Net
| -7.031 | -3.037 | -2.416 | -3.103 | 8.967 | -33.397 | -39.212 | -21.24 | -14.183 | 2.508 | -45.477 | -127.283 | -132.606 | -125.633 | -93.491 | 149.213 | 29.8 | -96.32 | -175.261 | -61.824 | -35.71 | -22.816 | -2.648 | 15.627 | -4.753 | -8.942 | -0.678 | -9.077 | -4.914 |
Income Before Tax
| 688.109 | 660.392 | 458.011 | 217.193 | 189.005 | 97.589 | 44.425 | 68.779 | 92.259 | 147.841 | 88.639 | 27.36 | 33.027 | 14.275 | -21.282 | 199.986 | 85.515 | -93.125 | -620.64 | -223.89 | 36.613 | 50.122 | 102.172 | 144.892 | 98.355 | 34.734 | 24.381 | 19.74 | 12.502 |
Income Before Tax Ratio
| 0.295 | 0.275 | 0.232 | 0.207 | 0.206 | 0.113 | 0.065 | 0.121 | 0.184 | 0.302 | 0.186 | 0.058 | 0.072 | 0.026 | -0.046 | 0.346 | 0.133 | -0.138 | -0.835 | -0.334 | 0.056 | 0.107 | 0.242 | 0.38 | 0.281 | 0.181 | 0.155 | 0.138 | 0.088 |
Income Tax Expense
| 75.998 | 72.702 | 66.471 | 34.509 | 31.167 | 22.649 | 29.18 | 24.458 | 25.419 | 40.909 | 24.634 | 24.825 | 29.079 | 25.184 | 18.719 | 14.153 | 10.582 | 8.126 | 1.225 | 3.264 | 6.511 | 2.784 | 0.35 | 1.189 | 3.288 | 7.293 | 3.705 | 3.139 | 4.146 |
Net Income
| 612.111 | 587.131 | 391.064 | 185.965 | 160.448 | 79.983 | 15.245 | 53.896 | 77.563 | 122.517 | 70.28 | 32.574 | 40.706 | 29.227 | 2.328 | 202.008 | 34.608 | -76.398 | -521.479 | -193.177 | 24.004 | 44.917 | 78.91 | 119.072 | 80.174 | 23.795 | 20.676 | 16.602 | 8.356 |
Net Income Ratio
| 0.263 | 0.244 | 0.198 | 0.177 | 0.175 | 0.093 | 0.022 | 0.095 | 0.155 | 0.25 | 0.147 | 0.069 | 0.088 | 0.054 | 0.005 | 0.349 | 0.054 | -0.113 | -0.702 | -0.288 | 0.037 | 0.096 | 0.187 | 0.312 | 0.229 | 0.124 | 0.131 | 0.116 | 0.059 |
EPS
| 0.84 | 0.8 | 0.55 | 0.38 | 0.33 | 0.15 | 0.029 | 0.094 | 0.14 | 0.23 | 0.13 | 0.062 | 0.097 | 0.072 | 0.005 | 0.49 | 0.082 | -0.18 | -1.23 | -0.46 | 0.058 | 0.11 | 0.21 | 0.28 | 0.31 | 0.098 | 0.094 | 0.13 | 0.02 |
EPS Diluted
| 0.84 | 0.8 | 0.55 | 0.38 | 0.33 | 0.15 | 0.029 | 0.094 | 0.14 | 0.23 | 0.13 | 0.062 | 0.097 | 0.072 | 0.005 | 0.49 | 0.082 | -0.18 | -1.23 | -0.46 | 0.058 | 0.11 | 0.21 | 0.28 | 0.31 | 0.098 | 0.094 | 0.13 | 0.02 |
EBITDA
| 695.14 | 805.128 | 622.398 | 285.406 | 269.352 | 180.015 | 131.02 | 156.223 | 178.22 | 269.762 | 206.983 | 159.411 | 179.202 | 183.332 | 124.925 | 304.553 | 235.962 | 74.774 | -460.831 | -119.454 | 103.815 | 103.159 | 144.87 | 140.53 | 96.429 | 50.381 | 24.422 | 20.689 | 18.613 |
EBITDA Ratio
| 0.299 | 0.335 | 0.316 | 0.272 | 0.294 | 0.209 | 0.191 | 0.275 | 0.356 | 0.551 | 0.433 | 0.339 | 0.389 | 0.336 | 0.268 | 0.526 | 0.366 | 0.111 | -0.62 | -0.178 | 0.159 | 0.22 | 0.343 | 0.369 | 0.276 | 0.263 | 0.155 | 0.144 | 0.131 |